QELBREE
NDC 17772-133, viloxazine hydrochloride, capsule, extended release, from Supernus Pharmaceuticals, Inc.
- Product NDC
- 17772-133
- Status
- Listed
- Labeler
- Supernus Pharmaceuticals, Inc
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211964
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17772-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VILOXAZINE HYDROCHLORIDE200 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2B6 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Norepinephrine Reuptake Inhibitor [EPC]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17772-133-01 | 17772013301 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-01) |
| 17772-133-07 | 17772013307 | 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-07) |
| 17772-133-30 | 17772013330 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-30) |
| 17772-133-60 | 17772013360 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-60) |
| 17772-133-90 | 17772013390 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-133-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/aedf408d-0f84-418d-9416-7c39ddb0d29aNADAC price for package 17772013330
GET /v1/drugs/nadac/17772013330NADAC price for package 17772013360
GET /v1/drugs/nadac/17772013360
Use it
Look up 17772-133 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17772-133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17772-133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.